DV
Dividend Vision

NIKI — Niki BioSolutions, Inc.

Niki BioSolutions, Inc. (NIKI)

Niki BioSolutions, Inc. (Nasdaq: NIKI) is the continuing public entity formerly listed as Aptorum Group Ltd (APM); on 2026-07-20 Aptorum completed its merger with DiamiR Biosciences, redomiciled to Delaware, executed a 1-for-10 reverse split, and began trading as NIKI. Brain-health diagnostics and biopharma.

NIKI key facts

Asset type
Stock
Asset class
Equity
Inception date
07/20/2026
Last close
$8.81
Market cap
$6,816,318
Average volume
33470.0
Beta
0.178
Payout ratio
0.0
EPS
$-1.70